Tenofovir Af + Emtricitabine + Bictegravir Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: Bictegravir-50 mg + Emtricitabine-200 mg + TAF-25 mg
Reference Brands: Biktarvy(EU & US)
Category: Anti Viral
Tenofovir AF + Emtricitabine + Bictegravir is available in Tablet and strengths such as Bictegravir-50 mg + Emtricitabine-200 mg + TAF-25 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Tenofovir AF + Emtricitabine + Bictegravir is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Tenofovir AF + Emtricitabine + Bictegravir can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description: Biktarvy is a complete, once-daily antiretroviral therapy for HIV-1 infection, combining Bictegravir 50 mg, Emtricitabine 200 mg, and Tenofovir Alafenamide (TAF) 25 mg in a single tablet. Approved by both the FDA and EMA, Biktarvy is indicated for adults and pediatric patients (≥2 years, ≥14 kg) who are treatment-naïve or virologically suppressed. Bictegravir, a potent integrase inhibitor, offers a high barrier to resistance and does not require boosting agents. TAF enhances renal and bone safety over older TDF-based regimens. Biktarvy simplifies HIV management, supporting long-term viral suppression and patient adherence through convenient once-daily dosing, with or without food.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Enfuvirtide Acetate
Strength:
90 mg/vial
Form: Injection
Reference Brands: Fuzeon (USA/EU)
View Details
Etravirine
Strength:
25 mg, 100 mg, 200 mg
Form: Tablets
Reference Brands: Intelence (USA), Intelence (EU)
View Details
Quick Response Guaranteed | Verified Suppliers
